Home » Topics » Disease categories and therapies » Substance use and poisoning

Substance use and poisoning
RSS

HBED proposed as alternative to deferoxamine as iron chelator

March 2, 1998

Nicotine inhaler launched in U.S.

March 2, 1998

The role of dopamine D2 receptor in alcohol intake suppression

Feb. 17, 1998

Orally active iron chelators in development at Novartis

Feb. 16, 1998

TheraTech and SmithKline Beecham join forces on nicotine product

Feb. 3, 1998

Dual 5-HT reuptake inhibitors/5-HT1A antagonists developed at Lilly

Jan. 26, 1998

New chelating agent developed by Israeli researchers

Jan. 21, 1998

U.K. launch for inhaled nicotine replacement therapy

Dec. 23, 1997

Antizol cleared by FDA as first antidote for ethylene glycol poisoning

Dec. 19, 1997

U. of Florida prepares new metal chelators

Dec. 18, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 12, 2025.
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...